MedPath

Emergency Capsule Endoscopy in Severe GI-bleeding

Phase 2
Completed
Conditions
GI-bleeding
Interventions
Device: capsule endoscopy
Registration Number
NCT01584869
Lead Sponsor
Technical University of Munich
Brief Summary

Primary objective: Evaluation of capsule endoscopy in the emergency setting of severe GI-Bleeding.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

patients with signs of severe GI-bleeding (with melena or dark bloody stool) and hemodynamic instability (defined as (pre)collapse or MAP < 80 mmHg or HR > 110) and/or drop of hemoglobin > 2g/dl/d and/or need of transfusion of minimum of 2 packed red cells

Exclusion Criteria

missing consent form, pregnancy, origin of bleeding found in upper GI-endoscopy (e.g. blood in the stomach, ulcer, varices with signs of bleeding, mallory-weiss-tear, Angiodysplasia (with signs of bleeding), refluxesophagitis LA C or D) fresh bloody stool, known stenosis of the bowel, known site of bleeding, known inflammatory bowel disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
capsule endoscopycapsule endoscopy-
Primary Outcome Measures
NameTimeMethod
the influence of capsule endoscopy on guidance of further diagnostic or therapeutic procedures.after complete recruitment
Secondary Outcome Measures
NameTimeMethod
frequency of mid-GI-bleeding in all patients
diagnostic yieldafter complete recruitment

Trial Locations

Locations (1)

Klinikum rechts der Isar

🇩🇪

München, Bavaria, Germany

© Copyright 2025. All Rights Reserved by MedPath